New York State Common Retirement Fund
TMDX icon

New York State Common Retirement Fund’s Transmedics TMDX Stock Holding History

New York State Common Retirement Fund’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$835K Sell
12,568
-6,072
-33% -$514K ﹤0.01% 1811
2026
Q1 		$1.85M Hold
18,640
– – ﹤0.01% 1412
2025
Q4 		$2.27M Buy
18,640
+3,400
+22% +$427K ﹤0.01% 1346
2025
Q3 		$1.71M Sell
15,240
-134,406
-90% -$15.7M ﹤0.01% 1489
2025
Q2 		$20.1M Buy
149,646
+7,808
+6% +$857K 0.03% 444
2025
Q1 		$9.54M Buy
141,838
+69,523
+96% +$4.78M 0.01% 736
2024
Q4 		$4.51M Sell
72,315
-28,440
-28% -$2.65M 0.01% 1141
2024
Q3 		$15.8M Sell
100,755
-9,880
-9% -$1.52M 0.02% 588
2024
Q2 		$16.7M Buy
110,635
+24,909
+29% +$2.99M 0.02% 582
2024
Q1 		$6.34M Sell
85,726
-1,790
-2% -$148K 0.01% 1007
2023
Q4 		$6.91M Buy
87,516
+25,849
+42% +$1.56M 0.01% 996
2023
Q3 		$3.38M Sell
61,667
-4,242
-6% -$305K ﹤0.01% 1255
2023
Q2 		$5.54M Sell
65,909
-3,416
-5% -$261K 0.01% 1123
2023
Q1 		$5.25M Buy
69,325
+33,652
+94% +$2.33M 0.01% 1145
2022
Q4 		$2.2M Buy
35,673
+2,092
+6% +$111K ﹤0.01% 1585
2022
Q3 		$1.4M Buy
33,581
+14,897
+80% +$648K ﹤0.01% 1795
2022
Q2 		$588K Sell
18,684
-37
-0.2% -$987 ﹤0.01% 2281
2022
Q1 		$504K Hold
18,721
– – ﹤0.01% 2399
2021
Q4 		$359K Sell
18,721
-41
-0.2% -$1.03K ﹤0.01% 2619
2021
Q3 		$621K Sell
18,762
-4,143
-18% -$127K ﹤0.01% 2349
2021
Q2 		$760K Buy
22,905
+205
+0.9% +$5.68K ﹤0.01% 2361
2021
Q1 		$942K Buy
22,700
+1,000
+5% +$30.8K ﹤0.01% 2154
2020
Q4 		$432K Buy
21,700
+3,100
+17% +$45.9K ﹤0.01% 2425
2020
Q3 		$256K Hold
18,600
– – ﹤0.01% 2541
2020
Q2 		$333K Buy
18,600
+5,800
+45% +$90.7K ﹤0.01% 2421
2020
Q1 		$155K Hold
12,800
– – ﹤0.01% 2584
2019
Q4 		$243K Buy
12,800
+6,000
+88% +$110K ﹤0.01% 2653
2019
Q3 		$162K Hold
6,800
– – ﹤0.01% 2866
2019
Q2 		$197K Buy
+6,800
New +$186K ﹤0.01% 2820

Other funds holding TMDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

New York State Common Retirement Fund's TMDX Position: Q2 2026 in Review

New York State Common Retirement Fund reduced its Transmedics (TMDX) stake by 33% in Q2 2026, selling an estimated $514K and leaving 12,568 shares worth $835K. The position accounts for ﹤0.01% of the portfolio, ranked #1811.

New York State Common Retirement Fund first reported a position in TMDX in Q2 2019 and has held it in 29 quarters since. The position peaked at $20.1M in Q2 2025. 375 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.

  • New York State Common Retirement Fund held 12,568 shares of Transmedics worth $835K as of Q2 2026.
  • New York State Common Retirement Fund sold 6,072 Transmedics shares in Q2 2026, an estimated $514K.
  • Transmedics made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q2 2026, its #1811 holding.
  • New York State Common Retirement Fund first reported a position in Transmedics in Q2 2019 and has held it in 29 quarters since.
  • New York State Common Retirement Fund's Transmedics position peaked at $20.1M in Q2 2025.
  • 375 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.